THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS
Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
D. A. Tzerkovsky [verfasserIn] E. A. Maslakov [verfasserIn] D. A. Bagrintsev [verfasserIn] I. A. Semak [verfasserIn] Yu. L. Protopovich [verfasserIn] A. G. Chizh [verfasserIn] A. A. Tatur [verfasserIn] I. S. Fomenkov [verfasserIn] D. S. Stupak [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Biomedical Photonics - Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016, 7(2018), 2, Seite 37-49 |
|---|---|
| Übergeordnetes Werk: |
volume:7 ; year:2018 ; number:2 ; pages:37-49 |
| Links: |
|---|
| DOI / URN: |
10.24931/2413-9432-2018-7-2-37-49 |
|---|
| Katalog-ID: |
DOAJ085422789 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ085422789 | ||
| 003 | DE-627 | ||
| 005 | 20230410105037.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230311s2018 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.24931/2413-9432-2018-7-2-37-49 |2 doi | |
| 035 | |a (DE-627)DOAJ085422789 | ||
| 035 | |a (DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 050 | 0 | |a R855-855.5 | |
| 100 | 0 | |a D. A. Tzerkovsky |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. | ||
| 650 | 4 | |a злокачественные опухоли | |
| 650 | 4 | |a головной мозг | |
| 650 | 4 | |a глиома | |
| 650 | 4 | |a флуоресцентная диагностика | |
| 650 | 4 | |a интраоперационная фотодинамическая терапия | |
| 653 | 0 | |a Medical technology | |
| 700 | 0 | |a E. A. Maslakov |e verfasserin |4 aut | |
| 700 | 0 | |a D. A. Bagrintsev |e verfasserin |4 aut | |
| 700 | 0 | |a I. A. Semak |e verfasserin |4 aut | |
| 700 | 0 | |a Yu. L. Protopovich |e verfasserin |4 aut | |
| 700 | 0 | |a A. G. Chizh |e verfasserin |4 aut | |
| 700 | 0 | |a A. A. Tatur |e verfasserin |4 aut | |
| 700 | 0 | |a I. S. Fomenkov |e verfasserin |4 aut | |
| 700 | 0 | |a D. S. Stupak |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Biomedical Photonics |d Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016 |g 7(2018), 2, Seite 37-49 |w (DE-627)1760619809 |x 24139432 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2018 |g number:2 |g pages:37-49 |
| 856 | 4 | 0 | |u https://doi.org/10.24931/2413-9432-2018-7-2-37-49 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.pdt-journal.com/jour/article/view/235 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2413-9432 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2018 |e 2 |h 37-49 | ||
| author_variant |
d a t dat e a m eam d a b dab i a s ias y l p ylp a g c agc a a t aat i s f isf d s s dss |
|---|---|
| matchkey_str |
article:24139432:2018----::hrlopooyaiteaynhtetetfrmrrcretnmts |
| hierarchy_sort_str |
2018 |
| callnumber-subject-code |
R |
| publishDate |
2018 |
| allfields |
10.24931/2413-9432-2018-7-2-37-49 doi (DE-627)DOAJ085422789 (DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781 DE-627 ger DE-627 rakwb rus R855-855.5 D. A. Tzerkovsky verfasserin aut THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. злокачественные опухоли головной мозг глиома флуоресцентная диагностика интраоперационная фотодинамическая терапия Medical technology E. A. Maslakov verfasserin aut D. A. Bagrintsev verfasserin aut I. A. Semak verfasserin aut Yu. L. Protopovich verfasserin aut A. G. Chizh verfasserin aut A. A. Tatur verfasserin aut I. S. Fomenkov verfasserin aut D. S. Stupak verfasserin aut In Biomedical Photonics Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016 7(2018), 2, Seite 37-49 (DE-627)1760619809 24139432 nnns volume:7 year:2018 number:2 pages:37-49 https://doi.org/10.24931/2413-9432-2018-7-2-37-49 kostenfrei https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781 kostenfrei https://www.pdt-journal.com/jour/article/view/235 kostenfrei https://doaj.org/toc/2413-9432 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2018 2 37-49 |
| spelling |
10.24931/2413-9432-2018-7-2-37-49 doi (DE-627)DOAJ085422789 (DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781 DE-627 ger DE-627 rakwb rus R855-855.5 D. A. Tzerkovsky verfasserin aut THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. злокачественные опухоли головной мозг глиома флуоресцентная диагностика интраоперационная фотодинамическая терапия Medical technology E. A. Maslakov verfasserin aut D. A. Bagrintsev verfasserin aut I. A. Semak verfasserin aut Yu. L. Protopovich verfasserin aut A. G. Chizh verfasserin aut A. A. Tatur verfasserin aut I. S. Fomenkov verfasserin aut D. S. Stupak verfasserin aut In Biomedical Photonics Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016 7(2018), 2, Seite 37-49 (DE-627)1760619809 24139432 nnns volume:7 year:2018 number:2 pages:37-49 https://doi.org/10.24931/2413-9432-2018-7-2-37-49 kostenfrei https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781 kostenfrei https://www.pdt-journal.com/jour/article/view/235 kostenfrei https://doaj.org/toc/2413-9432 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2018 2 37-49 |
| allfields_unstemmed |
10.24931/2413-9432-2018-7-2-37-49 doi (DE-627)DOAJ085422789 (DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781 DE-627 ger DE-627 rakwb rus R855-855.5 D. A. Tzerkovsky verfasserin aut THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. злокачественные опухоли головной мозг глиома флуоресцентная диагностика интраоперационная фотодинамическая терапия Medical technology E. A. Maslakov verfasserin aut D. A. Bagrintsev verfasserin aut I. A. Semak verfasserin aut Yu. L. Protopovich verfasserin aut A. G. Chizh verfasserin aut A. A. Tatur verfasserin aut I. S. Fomenkov verfasserin aut D. S. Stupak verfasserin aut In Biomedical Photonics Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016 7(2018), 2, Seite 37-49 (DE-627)1760619809 24139432 nnns volume:7 year:2018 number:2 pages:37-49 https://doi.org/10.24931/2413-9432-2018-7-2-37-49 kostenfrei https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781 kostenfrei https://www.pdt-journal.com/jour/article/view/235 kostenfrei https://doaj.org/toc/2413-9432 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2018 2 37-49 |
| allfieldsGer |
10.24931/2413-9432-2018-7-2-37-49 doi (DE-627)DOAJ085422789 (DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781 DE-627 ger DE-627 rakwb rus R855-855.5 D. A. Tzerkovsky verfasserin aut THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. злокачественные опухоли головной мозг глиома флуоресцентная диагностика интраоперационная фотодинамическая терапия Medical technology E. A. Maslakov verfasserin aut D. A. Bagrintsev verfasserin aut I. A. Semak verfasserin aut Yu. L. Protopovich verfasserin aut A. G. Chizh verfasserin aut A. A. Tatur verfasserin aut I. S. Fomenkov verfasserin aut D. S. Stupak verfasserin aut In Biomedical Photonics Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016 7(2018), 2, Seite 37-49 (DE-627)1760619809 24139432 nnns volume:7 year:2018 number:2 pages:37-49 https://doi.org/10.24931/2413-9432-2018-7-2-37-49 kostenfrei https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781 kostenfrei https://www.pdt-journal.com/jour/article/view/235 kostenfrei https://doaj.org/toc/2413-9432 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2018 2 37-49 |
| allfieldsSound |
10.24931/2413-9432-2018-7-2-37-49 doi (DE-627)DOAJ085422789 (DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781 DE-627 ger DE-627 rakwb rus R855-855.5 D. A. Tzerkovsky verfasserin aut THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. злокачественные опухоли головной мозг глиома флуоресцентная диагностика интраоперационная фотодинамическая терапия Medical technology E. A. Maslakov verfasserin aut D. A. Bagrintsev verfasserin aut I. A. Semak verfasserin aut Yu. L. Protopovich verfasserin aut A. G. Chizh verfasserin aut A. A. Tatur verfasserin aut I. S. Fomenkov verfasserin aut D. S. Stupak verfasserin aut In Biomedical Photonics Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016 7(2018), 2, Seite 37-49 (DE-627)1760619809 24139432 nnns volume:7 year:2018 number:2 pages:37-49 https://doi.org/10.24931/2413-9432-2018-7-2-37-49 kostenfrei https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781 kostenfrei https://www.pdt-journal.com/jour/article/view/235 kostenfrei https://doaj.org/toc/2413-9432 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 7 2018 2 37-49 |
| language |
Russian |
| source |
In Biomedical Photonics 7(2018), 2, Seite 37-49 volume:7 year:2018 number:2 pages:37-49 |
| sourceStr |
In Biomedical Photonics 7(2018), 2, Seite 37-49 volume:7 year:2018 number:2 pages:37-49 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
злокачественные опухоли головной мозг глиома флуоресцентная диагностика интраоперационная фотодинамическая терапия Medical technology |
| isfreeaccess_bool |
true |
| container_title |
Biomedical Photonics |
| authorswithroles_txt_mv |
D. A. Tzerkovsky @@aut@@ E. A. Maslakov @@aut@@ D. A. Bagrintsev @@aut@@ I. A. Semak @@aut@@ Yu. L. Protopovich @@aut@@ A. G. Chizh @@aut@@ A. A. Tatur @@aut@@ I. S. Fomenkov @@aut@@ D. S. Stupak @@aut@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
1760619809 |
| id |
DOAJ085422789 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ085422789</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410105037.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2018 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.24931/2413-9432-2018-7-2-37-49</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ085422789</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R855-855.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. A. Tzerkovsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">злокачественные опухоли</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">головной мозг</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">глиома</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">флуоресцентная диагностика</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">интраоперационная фотодинамическая терапия</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical technology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Maslakov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Bagrintsev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. A. Semak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu. L. Protopovich</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. G. Chizh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Tatur</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. S. Fomenkov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. S. Stupak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Biomedical Photonics</subfield><subfield code="d">Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016</subfield><subfield code="g">7(2018), 2, Seite 37-49</subfield><subfield code="w">(DE-627)1760619809</subfield><subfield code="x">24139432</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:37-49</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.24931/2413-9432-2018-7-2-37-49</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.pdt-journal.com/jour/article/view/235</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2413-9432</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">37-49</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
D. A. Tzerkovsky |
| spellingShingle |
D. A. Tzerkovsky misc R855-855.5 misc злокачественные опухоли misc головной мозг misc глиома misc флуоресцентная диагностика misc интраоперационная фотодинамическая терапия misc Medical technology THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS |
| authorStr |
D. A. Tzerkovsky |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760619809 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
R855-855 |
| illustrated |
Not Illustrated |
| issn |
24139432 |
| topic_title |
R855-855.5 THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS злокачественные опухоли головной мозг глиома флуоресцентная диагностика интраоперационная фотодинамическая терапия |
| topic |
misc R855-855.5 misc злокачественные опухоли misc головной мозг misc глиома misc флуоресцентная диагностика misc интраоперационная фотодинамическая терапия misc Medical technology |
| topic_unstemmed |
misc R855-855.5 misc злокачественные опухоли misc головной мозг misc глиома misc флуоресцентная диагностика misc интраоперационная фотодинамическая терапия misc Medical technology |
| topic_browse |
misc R855-855.5 misc злокачественные опухоли misc головной мозг misc глиома misc флуоресцентная диагностика misc интраоперационная фотодинамическая терапия misc Medical technology |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Biomedical Photonics |
| hierarchy_parent_id |
1760619809 |
| hierarchy_top_title |
Biomedical Photonics |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760619809 |
| title |
THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS |
| ctrlnum |
(DE-627)DOAJ085422789 (DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781 |
| title_full |
THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS |
| author_sort |
D. A. Tzerkovsky |
| journal |
Biomedical Photonics |
| journalStr |
Biomedical Photonics |
| callnumber-first-code |
R |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
txt |
| container_start_page |
37 |
| author_browse |
D. A. Tzerkovsky E. A. Maslakov D. A. Bagrintsev I. A. Semak Yu. L. Protopovich A. G. Chizh A. A. Tatur I. S. Fomenkov D. S. Stupak |
| container_volume |
7 |
| class |
R855-855.5 |
| format_se |
Elektronische Aufsätze |
| author-letter |
D. A. Tzerkovsky |
| doi_str_mv |
10.24931/2413-9432-2018-7-2-37-49 |
| author2-role |
verfasserin |
| title_sort |
role of photodynamic therapy in the treatment of primary, recurrent and metastatic malignant brain tumors |
| callnumber |
R855-855.5 |
| title_auth |
THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS |
| abstract |
Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. |
| abstractGer |
Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. |
| abstract_unstemmed |
Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
2 |
| title_short |
THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS |
| url |
https://doi.org/10.24931/2413-9432-2018-7-2-37-49 https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781 https://www.pdt-journal.com/jour/article/view/235 https://doaj.org/toc/2413-9432 |
| remote_bool |
true |
| author2 |
E. A. Maslakov D. A. Bagrintsev I. A. Semak Yu. L. Protopovich A. G. Chizh A. A. Tatur I. S. Fomenkov D. S. Stupak |
| author2Str |
E. A. Maslakov D. A. Bagrintsev I. A. Semak Yu. L. Protopovich A. G. Chizh A. A. Tatur I. S. Fomenkov D. S. Stupak |
| ppnlink |
1760619809 |
| callnumber-subject |
R - General Medicine |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.24931/2413-9432-2018-7-2-37-49 |
| callnumber-a |
R855-855.5 |
| up_date |
2024-07-03T14:39:45.091Z |
| _version_ |
1803569159305428992 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ085422789</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410105037.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2018 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.24931/2413-9432-2018-7-2-37-49</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ085422789</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ53b9c05173264e9eadfd9a215f0a7781</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R855-855.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. A. Tzerkovsky</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY, RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months - for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">злокачественные опухоли</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">головной мозг</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">глиома</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">флуоресцентная диагностика</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">интраоперационная фотодинамическая терапия</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical technology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">E. A. Maslakov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Bagrintsev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. A. Semak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yu. L. Protopovich</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. G. Chizh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Tatur</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. S. Fomenkov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. S. Stupak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Biomedical Photonics</subfield><subfield code="d">Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association", 2016</subfield><subfield code="g">7(2018), 2, Seite 37-49</subfield><subfield code="w">(DE-627)1760619809</subfield><subfield code="x">24139432</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:7</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:37-49</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.24931/2413-9432-2018-7-2-37-49</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/53b9c05173264e9eadfd9a215f0a7781</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.pdt-journal.com/jour/article/view/235</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2413-9432</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">7</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">37-49</subfield></datafield></record></collection>
|
| score |
7.4020147 |